PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM

OMIM Update List for March, 1996

Please send your questions to the NCBI Help Desk.

March 31, 1996

New Entries:

601167 PURINERGIC RECEPTOR P2Y, G-PROTEIN COUPLED, 1; P2RY1

Changed Entries:

100500 ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER
126600 DOYNE HONEYCOMB DEGENERATION OF RETINA; DHD
133171 ERYTHROPOIETIN RECEPTOR; EPOR
160900 DYSTROPHIA MYOTONICA; DM
174050 POLYCYSTIC LIVER DISEASE; PLD
235400 HEMOLYTIC-UREMIC SYNDROME; HUS
305900 GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
306700 HEMOPHILIA A
600041 PURINERGIC RECEPTOR P2Y, G-PROTEIN COUPLED, 2; P2RY2

March 30, 1996

Changed Entries:

134797 FIBRILLIN-1; FBN1
141900 HEMOGLOBIN--BETA LOCUS; HBB
175100 ADENOMATOUS POLYPOSIS OF THE COLON; APC
176270 PRADER-WILLI SYNDROME; PWS
176860 PROTEIN C DEFICIENCY, CONGENITAL THROMBOTIC DISEASE DUE TO
191170 TUMOR PROTEIN p53; TP53
245349 LACTIC ACIDEMIA DUE TO DEFECT IN THE X-LIPOYL CONTAINING COMPONENT
261600 PHENYLKETONURIA; PKU1
262890 PLATELET RECEPTOR FOR FACTOR X, DEFICIENCY OF
266200 PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE
306700 HEMOPHILIA A
306900 HEMOPHILIA B; HEMB
313700 TESTICULAR FEMINIZATION SYNDROME; TFM
516003 COMPLEX I, SUBUNIT ND4; MTND4

March 29, 1996

New Entries:

601168 UNC-33-LIKE PHOSPHOPROTEIN

Changed Entries:

107580 TRANSCRIPTION FACTOR AP-2, ALPHA; TFAP2A
120150 COLLAGEN, TYPE I, ALPHA-1 CHAIN; COL1A1
120330 COLOBOMA OF OPTIC NERVE WITH RENAL DISEASE
134820 FIBRINOGEN--ALPHA POLYPEPTIDE CHAIN; FGA
151385 CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2
154700 MARFAN SYNDROME; MFS
163260 NUCLEAR FACTOR ERYTHROID-2-LIKE 1; NFE2L1
208530 ASPLENIA WITH CARDIOVASCULAR ANOMALIES
211970 CAMPOMELIC DYSPLASIA; CMD1
234200 HALLERVORDEN-SPATZ DISEASE
258865 ORAL-FACIAL-DIGITAL SYNDROME WITH RETINAL ABNORMALITIES
266600 REGIONAL ENTERITIS
273300 TESTICULAR TUMORS
300037 GLYPICAN-3; GPC3
600284 ELL GENE; ELL
600284 ELL GENE; ELL
600300 SOLUTE CARRIER FAMILY 1, MEMBER 2; SLC1A2
600300 SOLUTE CARRIER FAMILY 1, MEMBER 2; SLC1A2
600845 P2X RECEPTOR, SUBUNIT 1; P2X1
600990 LAGOPHTHALMIA WITH BILATERAL CLEFT LIP AND PALATE
601047 CAVEOLIN-1; CAV; CAV1
601059 ADENOSINE DEAMINASE, RNA-SPECIFIC; ADAR
601070 INTERLEUKIN-15 RECEPTOR, ALPHA; IL15RA
601083 CD4/CD8 T-CELL RATIO
601095 HARROD SYNDROME
601101 OSLER-RENDU-WEBER SYNDROME 3; ORW3
601146 CARTILAGE-DERIVED MORPHOGENETIC PROTEIN 1; CDMP1
601157 DEFENSIN 4, CORTICOSTATIN; DEF4

March 28, 1996

New Entries:

300044 TRANSKETOLASE-2; TKT2
601160 LISSENCEPHALY SYNDROME TYPE III
601161 TRISOMY 18-LIKE SYNDROME
601162 CATARACTS WITH MOTOR NEURONOPATHY, SHORT STATURE, AND SKELETAL ABNORMALITIES
601163 DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS
601164 EXTRAPYRAMIDAL DISORDER, PROGRESSIVE, WITH PRIMARY HYPOGONADISM AND
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,
601166 G-PROTEIN-COUPLED RECEPTOR 15; GPR15

Changed Entries:

106150 ANGIOTENSIN I; AGT
113811 COLLAGEN, TYPE XVII, ALPHA-1 POLYPEPTIDE; COL17A1
126700 DRUSEN OF BRUCH MEMBRANE
158340 MUCIN 1, URINARY; MUC1
179508 RAB1, MEMBER RAS ONCOGENE FAMILY; RAB1
186730 T-CELL GLYCOPROTEIN CD8B; CD8B
188395 THYMOSIN-BETA-4; TMSB4
190198 NOTCH (DROSOPHILA) HOMOLOG 1; NOTCH1
190198 NOTCH (DROSOPHILA) HOMOLOG 1; NOTCH1
270550 SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE
277730 WERNICKE-KORSAKOFF SYNDROME
300100 ADRENOLEUKODYSTROPHY; ALD
600381 CG-1 ANTIGEN; CG1
600443 GLUTAREDOXIN; GLRX
600823 PROTEASE, SERINE, 8; PRSS8
600827 PHOSPHODIESTERASE 6C, cGMP-SPECIFIC, CONE, ALPHA PRIME; PDE6C
600835 STROMAL CELL-DERIVED FACTOR 1; SDF1
600853 HEPARAN SULFATE-N-DEACETYLASE/N-SULFOTRANSFERASE; HSST
600853 HEPARAN SULFATE-N-DEACETYLASE/N-SULFOTRANSFERASE; HSST
600859 JTV1 GENE
600860 GENERAL TRANSCRIPTION FACTOR IIIA; GTF3A
600863 CASEIN KINASE 1, EPSILON; CSNK1E
600864 CASEIN KINASE 1, DELTA; CSNK1D
600881 CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS
600897 GAP JUNCTION PROTEIN, ALPHA-8, 50 kD; GJA8

March 27, 1996

New Entries:

601156 EOTAXIN
601159 CHEMOKINE (C-C) RECEPTOR 1; CMKBR1

Changed Entries:

109150 AZOREAN NEUROLOGIC DISEASE
118661 CHONDROITIN SULFATE PROTEOGLYCAN 2; CSPG2
120435 COLON CANCER, FAMILIAL, NONPOLYPOSIS TYPE 1; FCC1
125370 DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
126452 DOPAMINE RECEPTOR D4; DRD4
137241 GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR
143100 HUNTINGTON DISEASE; HD
145500 HYPERTENSION, ESSENTIAL
151400 LEUKEMIA, CHRONIC LYMPHATIC; CLL
159440 MYELIN PROTEIN ZERO; MPZ
160980 MYXOMA, SPOTTY PIGMENTATION, AND ENDOCRINE OVERACTIVITY
165370 APLYSIA RAS-RELATED HOMOLOG 6; ARH6
167771 PANCREATIC STONE PROTEIN, SECRETORY, 2; PSPS2
168461 CYCLIN D1; CCND1
217030 COMPLEMENT COMPONENT-3 INACTIVATOR, DEFICIENCY OF
222900 DISACCHARIDE INTOLERANCE I
227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FACC
264480 PSEUDOTRISOMY 13 SYNDROME
300028 U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT
309860 MONOAMINE OXIDASE B; MAOB
311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
600108 MATRIX METALLOPROTEINASE-13; MMP13
600846 P2X RECEPTOR, SUBUNIT 4; P2X4
600879 NUCLEAR RESPIRATORY FACTOR 1; NRF1
601075 APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION
601079 U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT
601080 U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT
601123 SIALYLTRANSFERASE 8; SIAT8
601150 DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 11; DDX11
601151 DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 12; DDX12

March 26, 1996

New Entries:

601157 DEFENSIN 4, CORTICOSTATIN; DEF4
601158 C-JUN KINASE; JNK1

Changed Entries:

104614 SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
104614 SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
104614 SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
109150 AZOREAN NEUROLOGIC DISEASE
111700 BLOOD GROUP--RHESUS SYSTEM Cc/Ee POLYPEPTIDES; RHC; RHE; RHCE
114000 CAFFEY DISEASE
118945 CILIARY NEUROTROPHIC FACTOR; CNTF
118946 CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR
122560 CORTICOTROPIN-RELEASING HORMONE; CRH
125370 DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
134920 FIBROBLAST GROWTH FACTOR-2; FGF2
137800 GLIOMA OF BRAIN
143100 HUNTINGTON DISEASE; HD
143100 HUNTINGTON DISEASE; HD
143100 HUNTINGTON DISEASE; HD
143100 HUNTINGTON DISEASE; HD
148067 KERATIN 16; KRT16; K16
148820 KLEIN-WAARDENBURG SYNDROME
158000 MONILETHRIX
159595 MYELOPROLIFERATIVE SYNDROME, TRANSIENT
160900 DYSTROPHIA MYOTONICA; DM
161800 NEMALINE MYOPATHY
161950 NEPHRITIS, IgA TYPE
164400 OLIVOPONTOCEREBELLAR ATROPHY I; OPCA I
165120 V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG; LYN
165160 V-JUN AVIAN SARCOMA VIRUS 17 ONCOGENE HOMOLOG; JUN
174900 POLYPOSIS COLI, JUVENILE TYPE
176807 PROSTATE CANCER; PRCA1
176876 PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, 11; PTPN11
180646 RNA, SMALL NUCLEOLAR E2; RNE2
180849 RUBINSTEIN SYNDROME
182870 SPECTRIN, BETA SUBUNIT; SPTB
182920 SPHEROID BODY MYOPATHY
186770 T-CELL LEUKEMIA-3; TCL3
188070 THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R
191090 TUBEROUS SCLEROSIS-4; TSC4
193300 VON HIPPEL-LINDAU SYNDROME; VHL
210900 BLOOM SYNDROME; BLM
216360 COACH SYNDROME
220290 DEAFNESS, NEUROSENSORY AUTOSOMAL RECESSIVE, 1; DFNB1
230400 GALACTOSEMIA
231670 GLUTARICACIDEMIA I
231680 GLUTARICACIDURIA IIA; GA IIA
232400 GLYCOGEN STORAGE DISEASE III
232400 GLYCOGEN STORAGE DISEASE III
232500 GLYCOGEN STORAGE DISEASE IV
246400 LETTERER-SIWE DISEASE
254770 MYOCLONIC EPILEPSY, JUVENILE; EJM1; EJM; JME
263520 POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II
267700 RETICULOSIS, FAMILIAL HISTIOCYTIC
267700 RETICULOSIS, FAMILIAL HISTIOCYTIC
300700 ALBINISM-DEAFNESS SYNDROME; ADFN; ALDS
308000 HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE; HPRT; HGPRT
309400 MENKES SYNDROME
309548 FRAGILE SITE, FOLIC ACID TYPE, RARE, FRA (X)(Q28); FRAXE
309548 FRAGILE SITE, FOLIC ACID TYPE, RARE, FRA(X)(q28); FRAXE
309550 FRAGILE SITE, FOLIC ACID TYPE, RARE, FRA(X)(q27.3)
600353 S100 CALCIUM-BINDING PROTEIN A7; S100A7
600471 DEFENSIN 6; DEF6
600472 DEFENSIN 5; DEF5
600542 CHONDROSARCOMA, MYXOID EXTRASKELETAL, FUSED TO EWS; CSMF
600674 MICROTIA-ANOTIA
600722 PALMITOYL-PROTEIN THIOESTERASE; PPT
600837 GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GDNF
600936 HYALURONAN-MEDIATED MOTILITY RECEPTOR; HMMR
600939 INTERLEUKIN-11 RECEPTOR, ALPHA; IL11RA
600947 HUNTINGTIN-ASSOCIATED PROTEIN; HAP1
600959 BETA COAT PROTEIN; COPB
600968 NA-CL COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT
600978 TUMOR NECROSIS FACTOR C; TNFC
600979 TUMOR NECROSIS FACTOR C RECEPTOR; TNFCR
601009 TIGHT JUNCTION PROTEIN 1; TJP1
601010 TRANSCRIPTION FACTOR-15; TCF15
601014 DISCS, LARGE (DROSOPHILA) HOMOLOG 1; DLG1
601023 VALOSIN-CONTAINING PROTEIN; VCP
601024 CLATHRIN ADAPTOR PROTEIN 50; CLAPM1
601026 CLATHRIN ADAPTOR PROTEIN, ALPHA SUBUNIT; CLAPA1
601029 PATERNALLY EXPRESSED GENE 3; PEG3
601031 RHOPHILIN
601032 SERINE-THREONINE PROTEIN KINASE N; PKN
601068 MYOCLONUS EPILEPSY, BENIGN ADULT FAMILIAL; MEBA
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22
601120 CADHERIN-5; CDH5
601120 CADHERIN-5; CDH5
601128 H3 HISTONE, FAMILY 3A; H3F3A
601144 RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION AND SUDDEN DEATH,
601149 ISOCITRATE DEHYDROGENASE 3 (NAD+) ALPHA; IDH3A

March 25, 1996

New Entries:

300042 ALOPECIA, CONGENITAL
300043 HEPATOMA-DERIVED GROWTH FACTOR; HDGF
601144 RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION AND SUDDEN DEATH,
601146 CARTILAGE-DERIVED MORPHOGENETIC PROTEIN 1; CDMP1
601147 CARTILAGE-DERIVED MORPHOGENETIC PROTEIN 2; CDMP2
601148 MITOCHONDRIAL CAPSULE SELENOPROTEIN; MCSP
601149 ISOCITRATE DEHYDROGENASE 3 (NAD+) ALPHA; IDH3A
601150 CHL1-RELATED HELICASE GENE-1; CHLR1
601151 CHL1-RELATED HELICASE GENE-2; CHLR2
601153 FRAGILE HISTIDINE TRIAD GENE; FHIT
601155 MINOR HISTOCOMPATIBILITY ANTIGEN HA-1; HA1

Changed Entries:

104311 ALZHEIMER DISEASE, FAMILIAL, TYPE 3; AD3
107400 PROTEASE INHIBITOR 1 (ANTI-ELASTASE), ALPHA-1-ANTITRYPSIN; PI
118504 CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
123837 CYCLIN E; CCNE
123838 CYCLIN C; CCNC
124010 CYTOCHROME P-450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4
124060 CYTOCHROME P-450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2
138319 GLUTATHIONE PEROXIDASE-2; GPX2
142410 TRANSCRIPTION FACTOR 1, HEPATIC; TCF1
144700 HYPERNEPHROMA
147650 ISOCITRIC DEHYDROGENASE 2 (NADP+), MITOCHONDRIAL; IDH2
147700 ISOCITRIC DEHYDROGENASE 1 (NADP+), SOLUBLE; IDH1
153330 LYSOSOME-ASSOCIATED MEMBRANE PROTEIN A; LAMP1
163800 NODAL RHYTHM
173445 PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE; PECAM1
173900 POLYCYSTIC KIDNEYS
176860 PROTEIN C DEFICIENCY, CONGENITAL THROMBOTIC DISEASE DUE TO
176886 PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR TYPE, GAMMA POLYPEPTIDE; PTPRG
177735 PSEUDOHYPOALDOSTERONISM, TYPE I
201250 ACROMESOMELIC DWARFISM
235200 HEMOCHROMATOSIS; HFE
264350 PSEUDOHYPOALDOSTERONISM, TYPE I; PHA1
300019 HOST CELL FACTOR C1; HCFC1
310300 MUSCULAR DYSTROPHY, TARDIVE, DREIFUSS-EMERY TYPE, WITH CONTRACTURES
600022 PROSTAGLANDIN I2 RECEPTOR; PTGIR
600228 SODIUM CHANNEL, NONVOLTAGE-GATED, 1; SCNN1A
600339 MOVED TO 300043
600436 GLUTATHIONE-S-TRANSFERASE THETA 1; GSTT1
600478 SUPERKILLER VIRALICIDIC ACTIVITY 2; SKIV2
600563 PROSTAGLANDIN F RECEPTOR (FP); PTGFR
600633 TREFOIL FACTOR 3, INTESTINAL; TFF3
600642 MINOR HISTOCOMPATIBILITY ANTIGEN HA-2; HA2
600760 SODIUM CHANNEL, NONVOLTAGE-GATED 1 BETA; SCNN1B
600865 NEUROENDOCRINE-SPECIFIC PROTEIN; NSP
600897 GAP JUNCTION PROTEIN, ALPHA-8, 50 kD; GJA8
601036 HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H-PRIME; HNRPH2
601151 CHL1-RELATED HELICASE GENE-2; CHLR2
Clinical Synopsis for 600542 CHONDROSARCOMA, MYXOID EXTRASKELETAL, FUSED TO EWS; CSMF

March 22, 1996

New Entries:

601152 PERIPHERAL NEUROPATHY AND OPTIC ATROPHY
601154 CARDIOMYOPATHY, FAMILIAL DILATED, 2; CMPD2

Changed Entries:

109270 SOLUTE CARRIER FAMILY 4, ANION EXCHANGER, MEMBER 1; SLC4A1
115200 CARDIOMYOPATHY, FAMILIAL IDIOPATHIC
118200 CHARCOT-MARIE-TOOTH DISEASE 1B; CMT1B
118210 CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, A; CMT2A
118210 CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, A; CMT2A
118220 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
118220 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
120360 MATRIX METALLOPROTEINASE-2; MMP2
160900 DYSTROPHIA MYOTONICA; DM
266500 REFSUM DISEASE
266500 REFSUM DISEASE
300300 BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
600049 MYELODYSPLASIA SYNDROME-ASSOCIATED SEQUENCE-1
600884 CARDIOMYOPATHY, FAMILIAL DILATED

March 21, 1996

New Entries:

601133 CYTOCHROME P450, SUBFAMILY IIG, OLFACTORY-SPECIFIC; CYP2G1
601141 POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; KCNA1B
601142 POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT; KCNA2B
601143 DYNACTIN 1; DCTN1
601145 CYSTATIN B; CST6

Changed Entries:

105150 AMYLOIDOSIS VI
114208 CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL
115197 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
125480 MANIC-DEPRESSIVE PSYCHOSIS, AUTOSOMAL
134797 FIBRILLIN-1; FBN1
141900 HEMOGLOBIN--BETA LOCUS; HBB
142230 HEMOPOIETIC PROGENITOR CELL ANTIGEN CD34; CD34
142360 HEPARIN COFACTOR II DEFICIENCY
145500 HYPERTENSION, ESSENTIAL
156790 MICROFIBRIL-ASSOCIATED PROTEIN 2; MFAP2
159440 MYELIN PROTEIN ZERO; MPZ
164740 V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E2 ONCOGENE HOMOLOG 2; ETS2
167800 PANCREATITIS, HEREDITARY
172410 PHOSPHOLIPASE A2, GROUP IB; PLA2G1B
180849 RUBINSTEIN SYNDROME
191170 TUMOR PROTEIN p53; TP53
216411 COCKAYNE SYNDROME, TYPE III
230400 GALACTOSEMIA
234200 HALLERVORDEN-SPATZ DISEASE
237500 HYPERBILIRUBINEMIA II
252100 MOHR SYNDROME
254800 MYOCLONUS EPILEPSY OF UNVERRICHT AND LUNDBORG
260490 PANOSTOTIC FIBROUS DYSPLASIA
263200 POLYCYSTIC KIDNEY AND HEPATIC DISEASE-1; PKHD1
308800 KERATOSIS FOLLICULARIS SPINULOSA DECALVANS CUM OPHIASI; KFSD
309200 MANIC-DEPRESSIVE PSYCHOSIS, X-LINKED
410000 AMELOGENIN, Y-CHROMOSOMAL; AMELY
600119 ADHALIN; ADL
600595 POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE, MOUSE TG737, HUMAN
600658 PROTEIN PHOSPHATASE 5, CATALYTIC SUBUNIT; PPP5C
600698 HIGH MOBILITY GROUP PROTEIN HMGI-C; HMGIC
600837 GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GDNF
600887 MutS HUMAN HOMOLOG 3; MSH3
601103 MICROFIBRIL-ASSOCIATED GLYCOPROTEIN 2; MAGP2

March 20, 1996

New Entries:

300041 GUANYLYL CYCLASE 2F, RETINAL; GUC2F
601134 INTEGRAL MEMBRANE PROTEIN 1; IGM1
601135 GASTRULATION AND BRAIN SPECIFIC-2; GBX2
601136 TRANSSUPPRESSOR OF EXPRESSION-2; TSE2
601137 GUANYLYL CYCLASE, MEMBRANE, TYPE D; GUCY2D
601138 GUANYLYL CYCLASE, MEMBRANE, TYPE E; GUCY2E
601139 ZINC FINGER PROTEIN OTK18
601140 PHOSPHOLIPASE C-BETA-3 NEIGHBORING GENE; PNG

Changed Entries:

139313 GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA SUBUNIT (Gq CLASS); GNA11
158375 MUCIN 7, SALIVARY; MUC7
173350 PLASMINOGEN; PLG
235200 HEMOCHROMATOSIS; HFE
600179 GUANYLATE CYCLASE 2D, RETINAL; GUC2D
600678 G/T MISMATCH-BINDING PROTEIN; GTBP
600692 TROPONIN-T3, FAST SKELETAL; TNNT3
600821 ARGININE VASOPRESSIN RECEPTOR 1A; AVPR1A
600926 PROTEIN TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE
600926 PROTEIN TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE
601136 TRANSSUPPRESSOR OF EXPRESSION-2; TSE2

March 19, 1996

New Entries:

601132 KINASE SUPPRESSOR OF RAS; KSR

Changed Entries:

125370 DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
138400 GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPD
143100 HUNTINGTON DISEASE; HD
173350 PLASMINOGEN; PLG
173350 PLASMINOGEN; PLG
600673 UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF
601128 H3 HISTONE, FAMILY 3A; H3F3A

March 18, 1996

New Entries:

601114 DISCS, LARGE (DROSOPHILA) HOMOLOG 3; DLG3
601115 GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3
601116 GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8
601117 THIMET OLIGOPEPTIDASE 1; THOP1
601118 CALCIUM-MODULATING CYCLOPHILIN LIGAND; CAMLG
601128 NEW ENTRY: H3F3A, Histone type 3A
601129 CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 8; CYP2C8
601130 CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
601131 CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 18; CYP2C18

Changed Entries:

107580 TRANSCRIPTION FACTOR AP-2, ALPHA; TFAP2A
107580 TRANSCRIPTION FACTOR AP-2, ALPHA; TFAP2A
107970 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
124020 CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
130500 ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41
137025 FYN ONCOGENE RELATED TO SRC, FGR, YES; FYN
162642 NEUROPEPTIDE Y Y2 RECEPTOR; NPY2R
164940 GARDNER-RASHEED FELINE SARCOMA VIRAL (V-FGR) ONCOGENE; FGR
190090 V-SRC AVIAN SARCOMA (SCHMIDT-RUPPIN A-2) VIRAL ONCOGENE; SRC
305360 MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1
600267 PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, 13; PTPN13
600673 UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF
600944 DEOXYHYPUSINE SYNTHASE; DHPS

March 15, 1996

Changed Entries:

104614 SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
120140 COLLAGEN, TYPE II, ALPHA-1 CHAIN; COL2A1
120140 COLLAGEN, TYPE II, ALPHA-1 CHAIN; COL2A1
125480 MAJOR AFFECTIVE DISORDER 1; MAFD1
125480 MANIC-DEPRESSIVE PSYCHOSIS, AUTOSOMAL
137295 GATA-BINDING PROTEIN 2; GATA2
143100 HUNTINGTON DISEASE; HD
150310 LAMININ, BETA 3; LAMB3
151385 CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2
154700 MARFAN SYNDROME; MFS
156845 MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
165215 ECTROPIC VIRAL INTEGRATION SITE-1; EVI1
180474 RIBOSOMAL PROTEIN L22; RPL22
191092 TUBEROUS SCLEROSIS-2; TSC2
220100 CYSTINURIA; CSNU
220110 CYTOCHROME-c-OXIDASE DEFICIENCY
226700 EPIDERMOLYSIS BULLOSA LETALIS
232300 GLYCOGEN STORAGE DISEASE II
305371 GATA-BINDING PROTEIN 1; GATA1
305900 GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
309200 MAJOR AFFECTIVE DISORDER 2; MAFD2
309200 MANIC-DEPRESSIVE PSYCHOSIS, X-LINKED
309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;
600049 MYELODYSPLASIA SYNDROME-ASSOCIATED SEQUENCE-1
600918 CYSTINURIA, TYPE III; CSNU3
601121 PLACENTAL GROWTH FACTOR; PGF

March 14, 1996

New Entries:

300039 POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4
300040 SEGREGATION OF MITOTIC CHROMOSOMES, 1; SMC1;
601126 TATA ELEMENT MODULATORY FACTOR 1; TMF1
601127 FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION
Clinical Synopsis for 300039 POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4

Changed Entries:

106180 ANGIOTENSIN I CONVERTING ENZYME; ACE; ACE1
109400 BASAL CELL NEVUS SYNDROME; BCNS
111400 BLOOD GROUP--P SYSTEM
117550 CEREBRAL GIGANTISM
123812 CYCLIC-AMP-RESPONSE-ELEMENT MODULATOR; CREM
125480 DEPRESSIVE DISORDER
142925 HLA-H HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLAH
152790 LUTEINIZING HORMONE-CHORIOGONADOTROPIN RECEPTOR; LHCGR
157975 MOVED TO 172411
164905 ONCOGENE RCK; RCK
172411 PHOSPHOLIPASE A2, GROUP 2A; PLA2G2A
172411 PHOSPHOLIPASE A2, GROUP IIA; PLA2G2A
175200 POLYPOSIS, HAMARTOMATOUS INTESTINAL
217095 CONOTRUNCAL HEART MALFORMATIONS; CTHM
222400 DIAPHRAGM, UNILATERAL AGENESIS OF
263520 POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II
264480 PSEUDOTRISOMY 13 SYNDROME
276903 MYOSIN VIIA; MYO7A
300039 POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4
300040 SEGREGATION OF MITOTIC CHROMOSOMES, 1; SMC1
304400 DEAFNESS, CONDUCTIVE, WITH STAPES FIXATION
309550 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28
310300 MUSCULAR DYSTROPHY, TARDIVE, DREIFUSS-EMERY TYPE, WITH CONTRACTURES
314690 XE169 GENE; XE169;
600420 MOVED TO 300039
600420 MOVED TO 300039
600476 MOVED TO 300040
Clinical Synopsis for 600420 MOVED TO 300039

March 13, 1996

New Entries:

601120 CADHERIN-5; CDH5
601121 PLACENTAL GROWTH FACTOR; PIGF
601122 SEROTONIN 5-HT-2B RECEPTOR; HTR2B
601123 SIALYLTRANSFERASE 8; SIAT8
601124 SEMAPHORIN III/F; SEMA3F
601125 HEXOKINASE 2; HK2

Changed Entries:

103720 ALCOHOL DEHYDROGENASE-2; ADH2
115197 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
123000 CRANIOMETAPHYSEAL DYSPLASIA, DOMINANT TYPE
125310 DEMENTIA, HEREDITARY MULTI-INFARCT TYPE
125370 DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
138251 GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE A; GRINA
141500 HEMIPLEGIC MIGRAINE, FAMILIAL; MHP
154200 NAD-DEPENDENT MDH; MDH1
176916 PROTEIN PHOSPHATASE 2A, CATALYTIC SUBUNIT, BETA ISOFORM; PPP2CB
181500 SCHIZOPHRENIA-2
182135 SEROTONIN 5-HT-2A RECEPTOR; HTR2A
189964 GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 2; GTF2E2
192240 VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF
216400 COCKAYNE SYNDROME, TYPE I; CKN1
259730 OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS
300300 AGAMMAGLOBULINEMIA
300300 AGAMMAGLOBULINEMIA
301500 ANGIOKERATOMA, DIFFUSE
314690 XE169 GENE; XE169;
400001 SELECTED MOUSE cDNA ON Y, HUMAN HOMOLOG OF; SMCY
600025 KINESIN 2; KNS2
600056 MOVED TO 314690
600864 CASEIN KINASE 1, DELTA; CSNK1D
600864 CASEIN KINASE 1, DELTA; CSNK1D
600939 INTERLEUKIN-11 RECEPTOR, ALPHA; IL11RA
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22

March 12, 1996

Changed Entries:

103500 ALBINISM-DEAFNESS OF TIETZ
118220 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1a; CMT1A
134797 FIBRILLIN-1; FBN1
143110 HLA-F HISTOCOMPATIBILITY TYPE; HLAF
148820 KLEIN-WAARDENBURG SYNDROME
154700 MARFAN SYNDROME; MFS
180849 RUBINSTEIN SYNDROME
193500 WAARDENBURG SYNDROME; WS1
208900 ATAXIA-TELANGIECTASIA; AT
600392 RAD52, YEAST, HUMAN HOMOLOG OF; RAD52
600638 FIBROSIS, CONGENITAL, OF VERTICALLY ACTING EXTRAOCULAR MUSCLES
600947 HUNTINGTIN-ASSOCIATED PROTEIN; HAP1
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22

March 11, 1996

New Entries:

601119 CLPP PROTEASE

Changed Entries:

104230 ALPHA-3-FUCOSYLTRANSFERASE; FCT3A; CD15
107820 ARGINYL-tRNA SYNTHETASE; RARS
109535 B-CELL ASSOCIATED MOLECULE CD40; CD40
113650 BRANCHIOOTORENAL DYSPLASIA
131230 ENDONEXIN II; ENX2
131240 ENDOTHELIN-1; EDN1; ET1
138970 COLONY-STIMULATING FACTOR-3; CSF3
141900 HEMOGLOBIN--BETA LOCUS; HBB
142946 HOLOPROSENCEPHALY, TYPE 4; HPE4
157170 MIDLINE CLEFT SYNDROME
162200 NEUROFIBROMATOSIS, TYPE I; NF1
167770 REGENERATING ISLET-DERIVED 1-ALPHA; REG1A
167771 PANCREATIC STONE PROTEIN, SECRETORY, 2; PSPS2
176797 PROMYELOCYTIC LEUKEMIA ZINC FINGER; PLZF
181500 SCHIZOPHRENIA-2
194550 ZINC FINGER PROTEIN-42; ZNF42
202700 AGRANULOCYTOSIS, INFANTILE GENETIC
236100 HOLOPROSENCEPHALY, FAMILIAL ALOBAR
236100 HOLOPROSENCEPHALY, FAMILIAL ALOBAR
301500 ANGIOKERATOMA, DIFFUSE
311770 PHOSPHATIDYLINOSITOL GLYCAN CLASS A; PIGA
600270 PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER; PCOLCE
600379 MYELIN TRANSCRIPTION FACTOR 1; MYT1
600380 UBIQUITOUSLY EXPRESSED NUCLEAR RECEPTOR; UNR
600530 SOLUTE CARRIER FAMILY 9, MEMBER A2; SLC9A2
600531 SOLUTE CARRIER FAMILY 9, ISOFORM A4; SLC9A4
600892 SINGLE-MINDED DROSOPHILA, HUMAN HOMOLOG OF; SIM
601104 PROGRESSIVE SUPRANUCLEAR PALSY

March 10, 1996

New Entries:

601111 NADPH-FLAVIN REDUCTASE; FLR
601112 THIOREDOXIN REDUCTASE; TXNR
601113 HEAT SHOCK 70 PROTEIN 4; HSPA4

Changed Entries:

108725 ATHEROGENIC LIPOPROTEIN PHENOTYPE; ALP
159440 MYELIN PROTEIN ZERO; MPZ
166945 MEMBRANE COMPONENT, CHROMOSOME 17, SURFACE MARKER 2; M17S2
256731 CEROID-LIPOFUSCNOSIS, NEURONAL 5; CLN5
309550 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28
516060 COMPLEX V, ATP SYNTHASE, SUBUNIT ATPase 6; MTATP6; ATP6
600019 CYTOCHROME b561; CYB561
600538 PEROXIDE REDUCTASE, THIOREDOXIN-DEPENDENT; TDPX1
600538 PEROXIDE REDUCTASE, THIOREDOXIN-DEPENDENT; TDPX1
600548 MORTALIN-2; MOT2
600735 INTERFERON INDUCIBLE PROTEIN, 35-KD; IFP35
600747 T-BOX PROTEIN 2; TBX2

March 9, 1996

New Entries:

601107 MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT
601108 INTERLEUKIN-1-ASSOCIATED KINASE; IRAK
601109 SEROTONIN 5-HT-6 RECEPTOR; HTR6
601110 CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE IV

Changed Entries:

118425 CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1
121014 CONNEXIN 43 GAP JUNCTION PROTEIN; CX43
147421 INCLUSION BODY MYOSITIS; IBM
147450 SUPEROXIDE DISMUTASE-1; SOD1
156225 LAMININ, ALPHA 2; LAMA2
176260 POTASSIUM VOLTAGE-GATED CHANNEL, SHAKER-RELATED SUBFAMILY, MEMBER
176640 PRION PROTEIN; PRNP
181500 SCHIZOPHRENIA-2
186990 T-LYMPHOCYTE SURFACE CD2 ANTIGEN; CD2
231670 GLUTARICACIDEMIA I
237500 HYPERBILIRUBINEMIA II
256730 CEROID-LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
260565 PEHO SYNDROME
304040 CONNEXIN 32 GAP JUNCTION PROTEIN; CX32
310200 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER
600555 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1
600556 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2
600556 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2
600557 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3
600558 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4; STAT4
601007 LEPTIN RECEPTOR; OBR
601109 SEROTONIN 5-HT-6 RECEPTOR; HTR6

March 8, 1996

New Entries:

601103 MICROFIBRIL-ASSOCIATED GLYCOPROTEIN 2; MAGP2

Changed Entries:

102642 STEROL O-ACYLTRANSFERASE; SOAT
156790 MICROFIBRIL-ASSOCIATED PROTEIN 2; MFAP2
229300 FRIEDREICH ATAXIA; FRDA
300032 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
302800 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED; CMTX1
601105 CATHEPSIN K; CTSK

March 7, 1996

Changed Entries:

104613 CHAPERONIN CONTAINING T-COMPLEX SUBUNIT 6; CCT6
104751 SERUM AMYLOID A, 2; SAA2
104760 AMYLOID BETA A4 PRECURSOR PROTEIN; APP
111300 BLOOD GROUP--MN LOCUS; MN
111740 BLOOD GROUP--Ss LOCUS; Ss
112267 BONE MORPHOGENETIC PROTEIN-7; BMP7
113810 BULLOUS PEMPHIGOID ANTIGEN-1; BPAG1; BP240
114761 CARBONIC ANHYDRASE V; CA V; CA5
114850 CARBOXYPEPTIDASE A1; CPA1
116805 CATENIN, ALPHA 1; CTNNA1
116957 CELLULAR PROTEIN p107; CP107
117700 CERULOPLASMIN; CP
120070 COLLAGEN, TYPE IV, ALPHA-3 CHAIN; COL4A3
120090 COLLAGEN, TYPE IV, ALPHA-2 CHAIN; COL4A2
120130 COLLAGEN, TYPE IV, ALPHA-1 CHAIN; COL4A1
120131 COLLAGEN, TYPE IV, ALPHA-4 CHAIN; COL4A4
120320 COLLAGEN, TYPE XII, ALPHA-1 CHAIN; COL12A1
126452 DOPAMINE RECEPTOR D4; DRD4
130050 EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
164500 OLIVOPONTOCEREBELLAR ATROPHY III
164761 RET PROTO-ONCOGENE; RET
164875 ONCOGENE VAV; VAV
183090 SPINOCEREBELLAR ATROPHY II
186940 T-CELL ANTIGEN T4/LEU3; CD4
193300 VON HIPPEL-LINDAU SYNDROME; VHL
266200 PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE
300032 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE
303630 COLLAGEN, TYPE IV, ALPHA-5 CHAIN; COL4A5
600160 CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A

March 6, 1996

New Entries:

601104 PROGRESSIVE SUPRANUCLEAR PALSY
601105 CATHESPIN K; CTSK
601106 BB1 GENE; BB1

Changed Entries:

107741 APOLIPOPROTEIN E; APOE
107741 APOLIPOPROTEIN E; APOE
113705 BREAST CANCER, TYPE 1; BRCA1
116952 CELL DIVISION CYCLE 42; CDC42
119530 OROFACIAL CLEFT 1; OFC1
125310 DEMENTIA, HEREDITARY MULTI-INFARCT TYPE
130190 ELECTROENCEPHALOGRAPHIC PATTERNS; EEG
143100 HUNTINGTON DISEASE; HD
156225 LAMININ, ALPHA 2; LAMA2
159595 MYELOPROLIFERATIVE SYNDROME, TRANSIENT
160120 MYOKYMIA WITH PERIODIC ATAXIA
160900 DYSTROPHIA MYOTONICA; DM
162200 NEUROFIBROMATOSIS, TYPE I; NF1
162200 NEUROFIBROMATOSIS, TYPE I; NF1
162500 NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP
168600 PARKINSONISM
168600 PARKINSONISM
170500 PERIODIC PARALYSIS II
176943 PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14
183085 SPINOCEREBELLAR ATAXIA 3; SCA3
219800 CYSTINOSIS, EARLY-ONSET OR INFANTILE NEPHROPATHIC TYPE
229300 FRIEDREICH ATAXIA; FRDA; FA
236200 HOMOCYSTINURIA
236670 HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA
249100 MEDITERRANEAN FEVER, FAMILIAL; MEF
253220 MUCOPOLYSACCHARIDOSIS TYPE VII
253300 SPINAL MUSCULAR ATROPHY I; SMA I
277900 WILSON DISEASE; WND
300300 AGAMMAGLOBULINEMIA
600765 MKN28 KINASE
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22

March 5, 1996

New Entries:

601097 PERIPHERAL MYELIN PROTEIN 22; PMP22

Changed Entries:

118200 CHARCOT-MARIE-TOOTH DISEASE; CMT1
118210 CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, A; CMT2A
118220 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1a; CMT1A
118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS
145900 HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
158580 MUSCULAR ATROPHY, DISTAL SPINAL, WITH VOCAL CORD PARALYSIS
160900 DYSTROPHIA MYOTONICA; DM
162100 NEURITIS WITH BRACHIAL PREDILECTION
162375 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING
170995 PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1
180630 DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 5; DDX5
180710 RNA, U3 SMALL NUCLEAR; RNU3
214400 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY
312080 PROTEOLIPID PROTEIN, MYELIN; PLP
600326 DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 6; DDX6
600326 DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 6; DDX6
600326 DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 6; DDX6
600361 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY WITH PYRAMIDAL FEATURES
600379 MYELIN TRANSCRIPTION FACTOR 1; MYT1
600630 UV-SENSITIVE SYNDROME; UVS
600882 CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, B; CMT2B
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22

March 4, 1996

New Entries:

601102 EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2; EIF4A2

Changed Entries:

110700 BLOOD GROUP--DUFFY SYSTEM; Fy
113811 COLLAGEN, TYPE XVII, ALPHA-1 POLYPEPTIDE; COL17A1
120110 COLLAGEN, TYPE X, ALPHA 1; COL10A1
120150 COLLAGEN, TYPE I, ALPHA-1 CHAIN; COL1A1
120160 COLLAGEN, TYPE I, ALPHA-2 POLYPEPTIDE; COL1A2
120327 MOVED TO 113811
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY
146880 IMMUNE RESPONSE ANTIGENS; HIa; DC1
147679 IL-1 RECEPTOR ANTAGONIST; IL1RN
152430 LONGEVITY
152690 THYROID AUTOANTIGEN 70 KD; G22P1
152690 THYROID AUTOANTIGEN 70 KD; G22P1
154700 MARFAN SYNDROME; MFS
155755 MELANOMA-ASTROCYTOMA SYNDROME
164810 V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; FOS
172425 PHOSPHOLIPID TRANSFER PROTEIN; PLTP
184755 STEROL CARRIER PROTEIN-2; SCP2
188300 THYMIDINE KINASE, SOLUBLE; TK1
191092 TUBEROUS SCLEROSIS-2; TSC2
191100 TUBEROUS SCLEROSIS-1; TSC1
192090 CADHERIN 1; CDH1
194364 X-RAY-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER 5; XRCC5
222600 DIASTROPHIC DYSPLASIA; DTD
226650 EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE
232300 GLYCOGEN STORAGE DISEASE II
245200 KRABBE DISEASE
264470 PSEUDONEONATAL ADRENOLEUKODYSTROPHY
276903 MYOSIN VIIA; MYO7A
300000 OPITZ G/BBB SYNDROME, X-LINKED
300011 ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE, INCLUDED; ATP7A
312080 PROTEOLIPID PROTEIN, MYELIN; PLP
424500 GONADOBLASTOMA; GBY
590050 TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1; MTTL1
600650 CARNITINE PALMITOYLTRANSFERASE II; CPT2
600717 COLLAGEN, TYPE XIX, ALPHA-1 POLYPEPTIDE; COL19A1
600717 COLLAGEN, TYPE XIX, ALPHA-1 POLYPEPTIDE; COL19A1
600717 COLLAGEN, TYPE XIX, ALPHA-1 POLYPEPTIDE; COL19A1
600972 ACHONDROGENESIS, TYPE IB
601064 BUTYRATE RESPONSE FACTOR 1, BRF1
Clinical Synopsis for 274800 THYROID HORMONOGENESIS, GENETIC DEFECT IN, IV

March 3, 1996

New Entries:

300038 NUCLEOTIDE RECEPTOR, URIDINE; NRU
601101 OSLER-RANDU-WEBER SYNDROME 3; ORW3

Changed Entries:

101000 NEUROFIBROMATOSIS, TYPE II
101200 ACROCEPHALOSYNDACTYLY TYPE I; ACS1
101600 ACROCEPHALOSYNDACTYLY TYPE V
101600 ACROCEPHALOSYNDACTYLY TYPE V; ACS5
106700 ANOMALOUS PULMONARY VENOUS RETURN; APVR
120140 ALPHA-1(II) COLLAGEN CHAIN; COL2A1
120140 COLLAGEN, TYPE II, ALPHA-1 CHAIN; COL2A1
139250 GROWTH HORMONE 1; GH1
147620 INTERLEUKIN-6; IL6
176943 PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14
178640 SURFACTANT-ASSOCIATED PROTEIN, PULMONARY-3; SFTP3
218030 CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
270400 SMITH-LEMLI-OPITZ SYNDROME
270400 SMITH-LEMLI-OPITZ SYNDROME
300000 OPITZ BBBG SYNDROME, TYPE I; BBBG1
304110 CRANIOFRONTONASAL DYSPLASIA; CFND
600160 CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A

March 1, 1996

New Entries:

601099 SRC-LIKE ADAPTER; ALA
601100 STRESS70 PROTEIN CHAPERONE, MICROSOME-ASSOCIATED; STCH

Changed Entries:

114030 CAFE-AU-LAIT SPOTS, MULTIPLE; CALM
125480 DEPRESSIVE DISORDER
136131 FLAVIN-CONTAINING MONOOXYGENASE 2; FMO2
173110 PITUITARY-SPECIFIC TRANSCRIPTION FACTOR 1; PIT1
191081 TRYPTASE, BETA; TPS2
191510 GENE UPSTREAM OF NRAS
203100 ALBINISM I
230450 GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE
239200 HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY; NSPH; NSHPT
305900 GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
309200 MANIC-DEPRESSIVE PSYCHOSIS
309200 MANIC-DEPRESSIVE PSYCHOSIS
516060 COMPLEX V, ATP SYNTHASE, SUBUNIT ATPase 6; MTATP6; ATP6
530000 KEARNS-SAYRE SYNDROME; KSS
600380 UBIQUITOUSLY EXPRESSED NUCLEAR RECEPTOR; UNR
600483 FIBROBLAST GROWTH FACTOR-8; FGF8
600975 GLAUCOMA, PRIMARY CONGENITAL, TYPE B; GLC3B
601015 NIEMANN-PICK DISEASE, TYPE C2; NPC2
601099 SRC-LIKE ADAPTER; SLA
601100 STRESS70 PROTEIN CHAPERONE, MICROSOME-ASSOCIATED, p60; STCH

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH